(Reuters) - LONDON, July 19 - Roche Holding AG does not intend to increase its $3 billion, or $75 a share, tender offer for U.S. diagnostics firm Ventana Medical Systems Inc , the Swiss group's chief executive said on Thursday.
"We've no intention to increase that price," Franz Humer told analysts at a post-results meeting in London.
Read more at Reuters.com Mergers News
"We've no intention to increase that price," Franz Humer told analysts at a post-results meeting in London.
Read more at Reuters.com Mergers News
No comments:
Post a Comment